Adenosine A1 Receptor Agonists as Clinically Viable Agents for Treatment of Ischemic Brain Disorders
- 1 October 1997
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 825 (1) , 23-29
- https://doi.org/10.1111/j.1749-6632.1997.tb48411.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- N-Substituted Adenosines as Novel Neuroprotective A1 Agonists with Diminished Hypotensive EffectsJournal of Medicinal Chemistry, 1999
- Species differences in ligand affinity at central A3‐adenosine receptorsDrug Development Research, 1994
- Adenosine A1 and A2 receptors: Structure–function relationshipsMedicinal Research Reviews, 1992
- Neuroprotective role of adenosine in cerebral ischaemiaTrends in Pharmacological Sciences, 1992
- Cerebral ischemia in gerbils: Postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophyllineJournal of Molecular Neuroscience, 1990
- How does adenosine inhibit transmitter release?Trends in Pharmacological Sciences, 1988
- Effect of Theophylline on Ischemically Induced Hippocampal Damage in Mongolian Gerbils: A Behavioral and Histopathological StudyJournal of Cerebral Blood Flow & Metabolism, 1987
- Endogenously Released Adenosine Regulates Excitability in the In Vitro HippocampusEpilepsia, 1980
- ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLSJournal of Neurochemistry, 1979
- Purinergic depression of neurons in different areas of the rat brainExperimental Neurology, 1977